Crickets

[anonymous]

Anyone there?

 

[anonymous]

No! They are all at Sonic!

 

[anonymous]

Did you expect more from Craig Falling I mean Allen?

 

[anonymous]

So when is the rest of Bio going to LCA? Can't be far off!

 

[anonymous]

Russian princess will buy it before Lca scraps the rest

 

[JJ Han]

So when is the rest of Bio going to LCA? Can't be far off!

2025 will be the year of easier M&A. The wrath of Khan will be no more. Bio getting profitable spells out the inevitable. No more monies in. Logal stated in Q3 that costs that we're (BioRef) incurring, those non-recurring costs, are the key for us to be able to get the business profitable. There's not significant investments that we need to make back into the business. There's not an expansion of the sales force or new product offerings or anything like that. It is simply just, now that we've closed the transaction with LabCorp, giving us the ability to reduce our infrastructure size and an existing footprint to get us to those profitability numbers. So, we're -- I'll call it weeks away from that point.